Skip to main content
. 2021 Aug 19;107(7):1633–1642. doi: 10.3324/haematol.2021.278663

Figure 4.

Figure 4.

Kaplan–Meier analysis of investigator-assessed progression-free survival according to baseline International Prognostic Index status and a total metabolic tumor volume cut-off of 366 cm3. Differences in progression-free survival (PFS) probability were significant between each subgroup (P<0.0001): IPI: International Prognostic Index; TMTV: total metabolic tumor volume.